Held at Surrey Innovation Boulevard’s Health Tech Innovation Foundation on Dec 14, 2015
Health Tech Innovation Foundation together with National Research Council-Industrial Research Assistance Program’s Biomedical Sector Team hosted a workshop on how Canadian Companies can obtain non-dilutive funding, directly or indirectly, from the US National Institutes of Health (NIH). The workshop was geared towards facilitating access to funding opportunities for Canadian SMEs from the NIH.
Selected companies also had the opportunity to have one on one meetings with the speakers and their IRAP-Industry Technology Advisor to discuss company specific funding opportunities.
Dr. Lenka Fedorkova– is a former Manager of SBIR/STTR Programs at the NIH; she is a recognized expert in commercialization strategy and has managed programs across all NIH Institutes/Centres including the flagship Commercialization Accelerator Program.
David Hood– Senior Advisor to the Principal Assistant for Acquisitions at the US Army Medical Research and Material Command (2004 through 2009), formerly the co-founder and President of Integrated Medical Systems and the co-inventor of the company’s core product line.
A panel discussion, followed the main presentations where previous NIH grant recipients from academia and industry shared their success stories and experiences while engaging in a discussion that was highly informative providing detailed insights into the NIH grant application process. 70 people attended the event including industry leaders, academics and advisors from granting agencies.
From left: Samudra Dissanayake (HTIF), David Hood (speaker), David MacDonald (speaker), Paul Barren (NRC-IRAP), Lenka Fedorkova (speaker)